INVL Private Equity Fund II, IFC, and ACP have acquired a stake in POLMED to enhance its oncology services, aiming to establish a leading healthcare institution in Poland.

Target Information

The consortium, comprising INVL Private Equity Fund II, the International Finance Corporation (IFC), and Accession Capital Partners (ACP), has successfully acquired a stake in POLMED, one of the largest healthcare groups in Poland. With the capital raised from this acquisition, POLMED has purchased the management of oncology centers known as KN Group. This strategic move is intended to bolster POLMED's capabilities and market position in the oncology sector. As stated by Luke Staniczek, the investment manager at INVL Private Equity Fund II for Poland, the consortium aims to create a leading healthcare institution in Poland that is modern and accessible nationwide, ensuring high-quality care and a wide range of diagnostic services for patients.

Founded in 1999, POLMED has grown to become a major player in Poland's private healthcare sector, with projected revenues exceeding €100 million in 2024. The organization provides outpatient care, imaging diagnostics, inpatient, and home rehabilitation services, operating 38 facilities with approximately 380 hospital beds and employing around 2,000 staff members. POLMED collaborates with over 4,000 medical partners throughout Poland, serving more than 4 million patients and providing services to over 3,500 companies annually.

Industry Overview in Poland

The healthcare sector in Poland has been experiencing significant evolution, driven by demographic shifts and increasing demand for specialized medical services. With a rapidly aging population and rising incidences of chronic diseases, the Polis